Vyepti Demonstrates Efficacy in Patients with Chronic Migraine and Medication-Overuse Headache
• The RESOLUTION trial demonstrated that Vyepti (eptinezumab) is effective for patients with chronic migraine and medication-overuse headache (MOH).
• Patients treated with Vyepti experienced statistically significant reductions in monthly migraine days (MMD) compared to placebo over weeks 1-4.
• A significantly greater proportion of patients treated with Vyepti no longer met the diagnostic criteria for chronic migraine or MOH after treatment.
• The trial confirmed the early onset of Vyepti’s efficacy, with significant reductions in pain severity and acute medication use.
© Copyright 2025. All Rights Reserved by MedPath